Back to mobile site
Get it on Google Play

60 Degrees Pharma gets safety board clearance for babesiosis trial

July 1, 2026 8:02 AM EDT Send to a Friend
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) announced that an independent Data Safety Monitoring Board has recommended continuation of its B-Free ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login